159 related articles for article (PubMed ID: 3780677)
21. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
Lund LR
FEBS Lett; 1996 Apr; 383(3):139-44. PubMed ID: 8925884
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.
Georg B; Helseth E; Lund LR; Skandsen T; Riccio A; Danø K; Unsgaard G; Andreasen PA
Mol Cell Endocrinol; 1989 Jan; 61(1):87-96. PubMed ID: 2501120
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
24. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints.
Busso N; Péclat V; So A; Sappino AP
Ann Rheum Dis; 1997 Sep; 56(9):550-7. PubMed ID: 9370880
[TBL] [Abstract][Full Text] [Related]
25. Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system.
Medcalf RL
J Biol Chem; 1992 Jun; 267(17):12220-6. PubMed ID: 1318313
[TBL] [Abstract][Full Text] [Related]
26. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression.
Lansink M; Koolwijk P; van Hinsbergh V; Kooistra T
Blood; 1998 Aug; 92(3):927-38. PubMed ID: 9680361
[TBL] [Abstract][Full Text] [Related]
27. Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator.
Jankun J; Maher VM; McCormick JJ
Cancer Res; 1991 Feb; 51(4):1221-6. PubMed ID: 1847659
[TBL] [Abstract][Full Text] [Related]
28. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
[TBL] [Abstract][Full Text] [Related]
29. Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids.
Hamilton JH; Bootes A; Phillips PE; Slywka J
Arthritis Rheum; 1981 Oct; 24(10):1296-303. PubMed ID: 7197936
[TBL] [Abstract][Full Text] [Related]
30. Induction of urokinase-type plasminogen activator receptor by IL-1 beta.
Hasegawa T; Sorensen L; Dohi M; Rao NV; Hoidal JR; Marshall BC
Am J Respir Cell Mol Biol; 1997 Jun; 16(6):683-92. PubMed ID: 9191470
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.
Andreasen PA; Pyke C; Riccio A; Kristensen P; Nielsen LS; Lund LR; Blasi F; Danø K
Mol Cell Biol; 1987 Aug; 7(8):3021-5. PubMed ID: 3118190
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoids inhibit induced and non-induced mRNA accumulation of genes encoding hyaluronan synthases (HAS): hydrocortisone inhibits HAS1 activation by blocking the p38 mitogen-activated protein kinase signalling pathway.
Stuhlmeier KM; Pollaschek C
Rheumatology (Oxford); 2004 Feb; 43(2):164-9. PubMed ID: 13130151
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: a molecular mechanism contributing to organ atrophy.
Zhang W; Watson CE; Liu C; Williams KJ; Werth VP
Biochem J; 2000 Jul; 349(Pt 1):91-7. PubMed ID: 10861215
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of the inhibition of interleukin-8 production by dexamethasone in a human fibrosarcoma cell line.
Mukaida N; Gussella GL; Kasahara T; Ko Y; Zachariae CO; Kawai T; Matsushima K
Immunology; 1992 Apr; 75(4):674-9. PubMed ID: 1592440
[TBL] [Abstract][Full Text] [Related]
35. Augmented induction by dexamethasone of metallothionein IIa messenger ribonucleic acid in fibroblasts from a patient with cortisol hyperreactive syndrome.
Fujii H; Iida S; Gomi M; Tsugawa M; Kitani T; Moriwaki K
J Clin Endocrinol Metab; 1993 Feb; 76(2):445-9. PubMed ID: 8432788
[TBL] [Abstract][Full Text] [Related]
36. Human synovial fibroblasts produce urokinase-type plasminogen activator.
Medcalf RL; Hamilton JA
Arthritis Rheum; 1986 Nov; 29(11):1397-401. PubMed ID: 3096341
[TBL] [Abstract][Full Text] [Related]
37. Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells.
Grimaldi G; Di Fiore P; Locatelli EK; Falco J; Blasi F
EMBO J; 1986 May; 5(5):855-61. PubMed ID: 2424752
[TBL] [Abstract][Full Text] [Related]
38. Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.
Stoppelli MP; Verde P; Grimaldi G; Locatelli EK; Blasi F
J Cell Biol; 1986 Apr; 102(4):1235-41. PubMed ID: 3958045
[TBL] [Abstract][Full Text] [Related]
39. Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes.
Seki T; Miyasu T; Noguchi T; Hamasaki A; Sasaki R; Ozawa Y; Okukita K; Declerck PJ; Ariga T
J Cell Physiol; 2001 Oct; 189(1):72-8. PubMed ID: 11573206
[TBL] [Abstract][Full Text] [Related]
40. Tyrosine phosphorylation of human urokinase-type plasminogen activator.
Barlati S; Paracini F; Bellotti D; De Petro G
FEBS Lett; 1991 Apr; 281(1-2):137-40. PubMed ID: 1901800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
